International Meeting for Autism Research 2012 International Meeting for Autism Research 2012 | Spectrum | Autism Research News Skip to main content

Spectrum: Autism Research News

NEWS /

International Meeting for Autism Research 2012

IMFAR 2012

Brain trust

by  /  1 June 2012
Preliminary research shows that in people with autism, oxytocin enhances activity in brain areas that process social information.
IMFAR 2012

In autism, head growth patterns vary by gender

by  /  24 May 2012
Girls diagnosed with autism have slower brain growth in the first year of their life than typically developing children, whereas boys’ brains grow at the same rate as those of typical children, according to a population-based study in Norway.
IMFAR 2012

New report finds DSM-5 criteria unlikely to exclude many

by  /  24 May 2012
Contrary to previous studies, preliminary results from field trials of the new criteria for diagnosing autism suggest it will capture people on the high-functioning end of the spectrum.
May 2012
IMFAR 2012

Early data suggest antibiotic helps treat fragile X syndrome

by  /  19 May 2012

Preliminary results from a placebo-controlled trial of the antibiotic minocycline in children with fragile X syndrome suggest the drug alleviates some aspects of the disorder, according to research presented Friday at the International Meeting for Autism Research in Toronto.

0 Comments
IMFAR 2012

Why it’s good to share your data

by  /  18 May 2012

Neuroscience funding has plateaued, so researchers need to squeeze every drop from existing data.

1 Comment
IMFAR 2012

Long-term project charts methylation patterns in pregnancy

by  /  18 May 2012

By studying pregnant women who already have a child with autism, researchers hope to understand how epigenetic changes — those that affect gene expression but don’t directly alter DNA — during pregnancy influences risk of the disorder.

0 Comments
IMFAR 2012

Giving fathers oxytocin boosts levels in babies

by  /  17 May 2012

Two new studies on oxytocin, the so-called ‘trust hormone,’ suggest new avenues for using the drug to treat autism.

0 Comments